About Bio Capital Impact Fund
Bio Capital Impact Fund is a Financial Services company based in Melbourne (Australia). Investment in biotech technologies is managed for societal impact. It operates on a Commission-Based model. Bio Capital Impact Fund offers products and services including Impact Investment Fund. Its focus areas include Finance, Investment Management and Impact Investing.
Company details
Investment in innovative and disruptive biotech technologies is facilitated by Bio Capital Impact Fund. Focus is placed on medical, agricultural, and industrial sectors. High-growth, later-stage international investments are targeted to improve lives and society. A unique evergreen, open-ended fund structure is utilized to enable continuous deal flow and flexible reinvestment pathways. Strategic alliances with pharmaceutical companies, medical research institutes, and universities are built to support impactful outcomes. Management is based in Australia with global experience across Asia, Europe, and North America.
- Headquarters Melbourne, Australia
- SectorsFinancial Services
- Website bcif.com.au
Products & Services of Bio Capital Impact Fund
Bio Capital Impact Fund offers a comprehensive portfolio of products and services, including Impact Investment Fund.
Investment in biotech technologies is facilitated for impact.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bio Capital Impact Fund
Bio Capital Impact Fund is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Investment in innovative and disruptive biotech technologies is facilitated by Bio Capital Impact Fund. Focus is placed on medical, agricultural, and industrial sectors. High-growth, later-stage international investments are targeted to improve lives and society. A unique evergreen, open-ended fund structure is utilized to enable continuous deal flow and flexible reinvestment pathways. Strategic alliances with pharmaceutical companies, medical research institutes, and universities are built to support impactful outcomes. Management is based in Australia with global experience across Asia, Europe, and North America.
Bio Capital Impact Fund offers Impact Investment Fund.